U.S. flag

An official website of the United States government

NM_001129820.2(SLFN14):c.652A>G (p.Lys218Glu) AND Platelet-type bleeding disorder 20

Germline classification:
Likely pathogenic (3 submissions)
Last evaluated:
May 5, 2021
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000210920.8

Allele description [Variation Report for NM_001129820.2(SLFN14):c.652A>G (p.Lys218Glu)]

NM_001129820.2(SLFN14):c.652A>G (p.Lys218Glu)

Gene:
SLFN14:schlafen family member 14 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
17q12
Genomic location:
Preferred name:
NM_001129820.2(SLFN14):c.652A>G (p.Lys218Glu)
HGVS:
  • NC_000017.11:g.35557411T>C
  • NG_051181.1:g.8431A>G
  • NM_001129820.2:c.652A>GMANE SELECT
  • NP_001123292.1:p.Lys218Glu
  • NP_001123292.1:p.Lys218Glu
  • LRG_1114t1:c.652A>G
  • LRG_1114:g.8431A>G
  • LRG_1114p1:p.Lys218Glu
  • NC_000017.10:g.33884430T>C
  • NM_001129820.1:c.652A>G
  • NM_001129820.2:c.652A>G
  • P0C7P3:p.Lys218Glu
Protein change:
K218E; LYS218GLU
Links:
UniProtKB: P0C7P3#VAR_075786; OMIM: 614958.0003; dbSNP: rs869320716
NCBI 1000 Genomes Browser:
rs869320716
Molecular consequence:
  • NM_001129820.2:c.652A>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Platelet-type bleeding disorder 20 (BDPLT20)
Identifiers:
MONDO: MONDO:0014830; MedGen: C4310797; OMIM: 616913

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000267588OMIM
no assertion criteria provided
Pathogenic
(Nov 2, 2023)
germlineliterature only

PubMed (1)
[See all records that cite this PMID]

SCV002023586Revvity Omics, Revvity
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(May 5, 2021)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV002515745ISTH-SSC Genomics in Thrombosis and Hemostasis, KU Leuven, Center for Molecular and Vascular Biology
no assertion criteria provided
Uncertain significanceunknownresearch

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
not providedunknownyesnot providednot providednot providednot providednot providedresearch

Citations

PubMed

SLFN14 mutations underlie thrombocytopenia with excessive bleeding and platelet secretion defects.

Fletcher SJ, Johnson B, Lowe GC, Bem D, Drake S, Lordkipanidzé M, Guiú IS, Dawood B, Rivera J, Simpson MA, Daly ME, Motwani J, Collins PW, Watson SP, Morgan NV; UK Genotyping and Phenotyping of Platelets study group..

J Clin Invest. 2015 Sep;125(9):3600-5. doi: 10.1172/JCI80347. Epub 2015 Aug 17.

PubMed [citation]
PMID:
26280575
PMCID:
PMC4588283

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From OMIM, SCV000267588.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)

Description

In a 3-year-old boy with platelet-type bleeding disorder-20 (BDPLT20; 616913), Fletcher et al. (2015) identified a heterozygous c.652A-G transition (c.652A-G, NM_001129820) in the SLFN14 gene, resulting in a lys218-to-glu (K218E) substitution in the ATPase-AAA-4 domain. The mutation was not found in the dbSNP (build 138) or ExAC databases. Patient cells showed decreased levels of SLFN14 protein to about 19% of control values.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

From Revvity Omics, Revvity, SCV002023586.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From ISTH-SSC Genomics in Thrombosis and Hemostasis, KU Leuven, Center for Molecular and Vascular Biology, SCV002515745.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedresearchnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 7, 2024